We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$3.28B
AUM Growth
+$597M
Cap. Flow
+$166M
Cap. Flow %
5.04%
Top 10 Hldgs %
22.55%
Holding
268
New
71
Increased
59
Reduced
39
Closed
90

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$77.8M
2
HST icon
Host Hotels & Resorts
HST
+$67.9M
3
WYNN icon
Wynn Resorts
WYNN
+$64.1M
4
IP icon
International Paper
IP
+$63.6M
5
AAP icon
Advance Auto Parts
AAP
+$56.4M

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$58.5M
2
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$57.9M
3
TNL icon
Travel + Leisure Co
TNL
+$56M
4
ONIT
Onity Group
ONIT
+$44.1M
5
EXP icon
Eagle Materials
EXP
+$42.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.75%
2 Healthcare 13.67%
3 Technology 10.55%
4 Financials 10.48%
5 Materials 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAR icon
1
Marriott International
MAR
$96.8B
$84.9M 2.59%
1,720,000
+890,000
+107% +$40.5M
HST icon
2
Host Hotels & Resorts
HST
$16.5B
$83.1M 2.53%
4,275,891
+3,675,891
+613% +$67.9M
C icon
3
Citigroup
C
$216B
$80.5M 2.45%
1,545,300
+328,511
+27% +$16.6M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$36.1B
$79.2M 2.41%
+1,975,045
New +$77.8M
WYNN icon
5
Wynn Resorts
WYNN
$9.93B
$73M 2.22%
+376,000
New +$64.1M
IP icon
6
International Paper
IP
$19.2B
$68.1M 2.07%
+1,486,320
New +$63.6M
JPM icon
7
JPMorgan Chase
JPM
$901B
$65.7M 2%
1,123,224
-26,269
-2% -$1.44M
AAP icon
8
Advance Auto Parts
AAP
$3.14B
$62.9M 1.91%
+567,863
New +$56.4M
BIIB icon
9
Biogen
BIIB
$29.5B
$57.9M 1.76%
206,959
+119,519
+137% +$30.9M
VAL
10
DELISTED
Valspar
VAL
$53M 1.61%
743,094
+392,568
+112% +$27.2M
CCK icon
11
Crown Holdings
CCK
$12.8B
$52.3M 1.59%
1,172,790
+69,690
+6% +$2.98M
CMCSA icon
12
Comcast
CMCSA
$84.9B
$52M 1.58%
2,000,000
+540,000
+37% +$13M
ZTS icon
13
Zoetis
ZTS
$31.9B
$49.7M 1.51%
1,519,583
-176,019
-10% -$5.61M
MO icon
14
Altria Group
MO
$125B
$47.6M 1.45%
1,240,000
-554,311
-31% -$20.5M
GEN icon
15
Gen Digital
GEN
$16.1B
$45.4M 1.38%
1,927,407
+1,538,325
+395% +$36M
MSFT icon
16
Microsoft
MSFT
$2.99T
$45.1M 1.37%
1,204,658
+442,658
+58% +$16.1M
TDC icon
17
Teradata
TDC
$2.88B
$44.2M 1.35%
+971,260
New +$44M
BHC icon
18
Bausch Health
BHC
$1.75B
$41.9M 1.28%
356,687
+279,254
+361% +$30.6M
ASML icon
19
ASML
ASML
$668B
$39.9M 1.22%
426,000
+282,760
+197% +$26.2M
QVCGA
20
DELISTED
QVC Group Inc Series A
QVCGA
$39.6M 1.21%
+32,871
New +$36.6M
TFCFA
21
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$38.7M 1.18%
+1,100,000
New +$37.1M
IVZ icon
22
Invesco
IVZ
$13.1B
$38.3M 1.17%
+1,050,967
New +$35.7M
AGU
23
DELISTED
Agrium
AGU
$37.8M 1.15%
+413,583
New +$36.5M
BEAM
24
DELISTED
BEAM INC COM STK (DE)
BEAM
$37.6M 1.15%
552,841
+45,573
+9% +$3.08M
DLR icon
25
Digital Realty Trust
DLR
$65.2B
$37M 1.13%
+753,602
New +$37.4M
1
2 3 4 5

Similar funds

MWAC
Mariner Wealth Advisors (Cincinnati) Cincinnati, Ohio $1.81B AUM 13.11% 1-Year Est. Return
TP
Tesuji Partners Fort Lee, New Jersey $1.73B AUM 3.93% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
RW
Rand Wealth Baltimore, Maryland $893M AUM 9.85% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AC
AFAM Capital Austin, Texas $718M AUM 12.09% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Ascend Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Ascend Capital held 268 positions worth $3.28B, up 22% from $2.69B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital deployed $166M of net new capital in Q4 2013, opening 71 new positions and adding to 59 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $57.9M trimmed.

  • Ascend Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.
  • Ascend Capital added most to Host Hotels & Resorts in Q4 2013, an estimated $67.9M increase.
  • Ascend Capital's biggest Q4 2013 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $57.9M.
  • Ascend Capital fully exited Perrigo in Q4 2013, selling an estimated $58.5M.
  • Ascend Capital's ten largest holdings make up 23% of its $3.28B portfolio in Q4 2013.
  • Ascend Capital opened 71 new positions and closed 90 in Q4 2013.
  • Ascend Capital's portfolio value rose 22% quarter-over-quarter to $3.28B.

Based on Ascend Capital's 13F filing for Q4 2013, filed 14 Feb 2014.